Fetal Growth Restriction Clinical Trials
2 recruiting trials for Fetal Growth Restriction. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Fetal Growth Restriction clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Institute of Health Information and Statistics of the Czech Republic (1), Liverpool School of Tropical Medicine (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is L-citrulline (dietary_supplement, 1 trial).
Track Fetal Growth Restriction trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
The Combined First Trimester Screening
The project is a national, prospective, multicenter pilot project. The project is focus on setting up the combined first trimester screening in the Czech Republic. The combined...
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
There are few safe, effective, and affordable interventions to improve pregnancy outcomes in low resource settings where the highest rates of poor birth outcomes occur....
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Fetal Growth Restriction, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Fetal Growth Restriction, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Fetal Growth Restriction, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.